These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 817293)

  • 41. Hepatitis A and B: serologic survey of human and nonhuman primate sera.
    Eichberg JW; Kalter SS
    Lab Anim Sci; 1980 Jun; 30(3):541-3. PubMed ID: 6253744
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Protective immunisation against hepatitis B with an internal antigen of the virus.
    Murray K; Bruce SA; Wingfield P; van Eerd P; de Reus A; Schellekens H
    J Med Virol; 1987 Oct; 23(2):101-7. PubMed ID: 2445909
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Poor efficacy of intradermal administration of recombinant hepatitis B virus immunization in HIV-infected individuals who fail to respond to intramuscular administration of hepatitis B virus vaccine.
    Shafran SD; Mashinter LD; Lindemulder A; Taylor GD; Chiu I
    HIV Med; 2007 Jul; 8(5):295-9. PubMed ID: 17561875
    [TBL] [Abstract][Full Text] [Related]  

  • 44. CD4+ T Cells Are Not Required for Suppression of Hepatitis B Virus Replication in the Liver of Vaccinated Chimpanzees.
    Rybczynska J; Campbell K; Kamili S; Locarnini S; Krawczynski K; Walker CM
    J Infect Dis; 2016 Jan; 213(1):49-56. PubMed ID: 26324781
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Hepatitis B antigens in serum and liver of chimpanzees acutely infected with hepatitis B virus.
    Berquist KR; Peterson JM; Murphy BL; Ebert JW; Maynard JE; Purcell RH
    Infect Immun; 1975 Sep; 12(3):602-5. PubMed ID: 1100525
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Differences in response to a hepatitis B vaccine booster dose among Alaskan children and adolescents vaccinated during infancy.
    Samandari T; Fiore AE; Negus S; Williams JL; Kuhnert W; McMahon BJ; Bell BP
    Pediatrics; 2007 Aug; 120(2):e373-81. PubMed ID: 17636112
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Some considerations regarding active immunization with HBsAg.
    Prince AM; Hashimoto N; Neurath AR; Trepo C
    Dev Biol Stand; 1975; 30():368-74. PubMed ID: 1204972
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Efficacy of hepatitis B vaccine against antiviral drug-resistant hepatitis B virus mutants in the chimpanzee model.
    Kamili S; Sozzi V; Thompson G; Campbell K; Walker CM; Locarnini S; Krawczynski K
    Hepatology; 2009 May; 49(5):1483-91. PubMed ID: 19274751
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Development and utilization of complement-fixation and immune adherence tests for human hepatitis A virus and antibody.
    Hilleman MR; Provost PJ; Miller WJ; Villarejos VM; Ittensohn OL; McAleer WJ
    Am J Med Sci; 1975; 270(1):93-8. PubMed ID: 53013
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Preparation and testing of a hepatitis B vaccine (author's transl)].
    Thomssen R; Gerlich W; Böttcher U; Stibbe W; Legler K; Weinmann E; Klinge O; Pfeifer U
    Dtsch Med Wochenschr; 1982 Jan; 107(4):125-31. PubMed ID: 7056165
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Inability to detect hepatitis B virus or specific antigens in transformed chimpanzee lymphocytes.
    Schable CA; Murphy BL; Berquist KR; Gravelle CR; Maynard JE
    Infect Immun; 1974 Dec; 10(6):1443-4. PubMed ID: 4373398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Markedly prolonged incubation period of hepatitis B in a chimpanzee passively immunized with a human monoclonal antibody to the a determinant of hepatitis B surface antigen.
    Ogata N; Ostberg L; Ehrlich PH; Wong DC; Miller RH; Purcell RH
    Proc Natl Acad Sci U S A; 1993 Apr; 90(7):3014-8. PubMed ID: 8464917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Approaching the control of viral hepatitis type B.
    Melnick JL; Dreesman GR; Hollinger FB
    J Infect Dis; 1976 Feb; 133(2):210-29. PubMed ID: 54398
    [No Abstract]   [Full Text] [Related]  

  • 54. Hepatitis B vaccine: efficacy in high-risk settings, a two-year study.
    Maupas P; Goudeau A; Coursaget P; Drucker J; Bagros P
    Intervirology; 1978; 10(3):196-208. PubMed ID: 681144
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Vaccination against hepatitis B in man].
    Maupas P; Goudeau A; Coursaget P; Drucker J; Bagros P; Baudin S
    Nouv Presse Med; 1977 Jan; 6(1):27-31. PubMed ID: 401985
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Primates as model for human viral hepatitis: transmission of infection by human hepatitis B virus.
    Desmyter J; Liu WT; de Somer P; Mortelmans J
    Vox Sang; 1973; 24():S:17-26. PubMed ID: 4198177
    [No Abstract]   [Full Text] [Related]  

  • 57. Nonresponse to hepatitis B vaccine in homosexual men.
    Ostrow DG; Goldsmith J; Kalish SB; Chmiel JS; Hadler SC; Phair JP
    Sex Transm Dis; 1987; 14(2):92-7. PubMed ID: 3649963
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Relationship of hepatitis A antigen to viral hepatitis.
    Purcell RH; Dienstag JL; Feinstone SM; Kapikian AZ
    Am J Med Sci; 1975; 270(1):61-71. PubMed ID: 53012
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Humoral and cellular immune responses to hepatitis B vaccination in hepatitis B surface antigen-carrier children who cleared serum-hepatitis B surface antigen.
    Hsu HY; Chang MH; Hsieh RP; Ni YH; Chi WK
    Hepatology; 1996 Dec; 24(6):1355-60. PubMed ID: 8938161
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Hepatitis B e antigen and infectivity of hepatitis B virus.
    Shikata T; Karasawa T; Abe K; Uzawa T; Suzuki H; Oda T; Imai M; Mayumi M; Moritsugu Y
    J Infect Dis; 1977 Oct; 136(4):571-6. PubMed ID: 908854
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.